Farmax India Ltd has informed BSE that the Board Meeting of the Company will be held on November 11, 2016, inter alia, to consider and approve the following:
1. Unaudited Q2 results for the quarter ended September 30, 2016.
2. Limited Review report for the quarter ended September 30, 2016.
In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of October 31, 2016 till day of November 11, 2016 (both days inclusive).
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
